| Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: a worldwide study JP Arab, LA Díaz, N Baeza, F Idalsoaga, E Fuentes-López, J Arnold, ... Journal of hepatology 75 (5), 1026-1033, 2021 | 67 | 2021 |
| MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis LA Díaz, E Fuentes-López, G Ayares, F Idalsoaga, J Arnold, MA Valverde, ... JHEP Reports 5 (8), 100727, 2023 | 6 | 2023 |
| Spontaneous bacterial peritonitis Ľ Skladaný, S Kasová, A Purgelová, N Bystrianska, ... Klinicka Mikrobiologie a Infekcni Lekarstvi 22 (4), 136-140, 2016 | 4 | 2016 |
| Acute-on-chronic liver failure: a single-centre experience Ľ Skladaný, D Janceková, J Vnenčáková, SA Selčanová, N Bystrianska, ... Clinical and Experimental Hepatology 6 (2), 92-98, 2020 | 2 | 2020 |
| Infection in patients hospitalised with advanced chronic liver disease (cirrhosis)-single-centre experience N Bystrianska, L Skladany, S Adamcova-Selcanova, J Vnencakova, ... Gastroenterol Hepatol 74, 111-5, 2020 | 2 | 2020 |
| Increased mortality and decreased registrations in cirrhosis registry during COVID-19 era L Skladaný, J Vnencakova, DJ Havaj, S Adamcova-Selcanova, ... Hepatology, 281A-281A, 2020 | 2 | 2020 |
| An Artificial Intelligence-Generated Model From A Global Cohort To Predict 90-Day Survival In Alcohol-Associated Hepatitis W Dunn, Y Li, AK Singal, DA Simonetto, L Antonio Diaz, ... Hepatology 76, S112-S113, 2022 | 1 | 2022 |
| De novo non-alcoholic fatty liver disease after liver tranplantation–as dia gnosed by magnetic resonance L Skladany, SA Selcanova, J Ciefova, N Bystrianska, B Skvarkova, ... morbidity and mortality 14, 19, 2020 | 1 | 2020 |
| P-19 CHARACTERIZATION, PROGNOSTIC FACTORS, AND SURVIVAL IN MODERATE ALCOHOL-ASSOCIATED HEPATITIS: A MULTICENTER STUDY F Idalsoaga, LA Díaz, O Corsi, G Ayares, J Arnold, W Dunn, Y Li, A Singal, ... Annals of Hepatology 29, 101206, 2024 | | 2024 |
| P-40 PENTOXIFYLLINE USE IN PATIENTS WITH ALCOHOL-ASSOCIATED HEPATITIS ADMITTED WITH ACUTE KIDNEY INJURY COULD DECREASE SURVIVAL: A GLOBAL STUDY F Idalsoaga, LA Diaz, O Corsi, G Ayares, J Arnold, W Dunn, Y Li, A Singal, ... Annals of Hepatology 29, 101227, 2024 | | 2024 |
| PRE-TREATMENT GUT MICROBIOTA PREDICTS SURVIVAL AFTER FECAL MICROBIOTA TRANSPLANTATION IN SEVERE ALCOHOLIC HEPATITIS L Skladany, K Soltys, N Bystrianska, D Zilincanova, SA Selcanova, ... HEPATOLOGY 78, S181-S182, 2023 | | 2023 |
| NEUTROPHILS-TO-LYMPHOCYTES RATIO ASSOCIATES WITH OUTCOME AND ETIOLOGY OF ACUTE DECOMPENSATION OF ADVANCED CHRONIC LIVER DISEASE L Skladany, D Zilincanova, DJ Havaj, N Bystrianska, SA Selcanova, ... HEPATOLOGY 78, S1625-S1626, 2023 | | 2023 |
| CHARACTERIZATION, PROGNOSTIC FACTORS, AND SURVIVAL IN MODERATE ALCOHOLASSOCIATED HEPATITIS: A MULTICENTER STUDY F Idalsoaga, LA Diaz, O Corsi, G Ayares, J Arnold, W Dunn, Y Li, ... HEPATOLOGY 78, S1587-S1588, 2023 | | 2023 |
| Concomitant diverticulosis among patients undergoing liver transplantation. Does it influence the length of hospitalization after the procedure? T Menżyk, L Skladany, S Adamcova-Selcanova, J Vnencakova, ... Clinical and Experimental Hepatology 9 (1), 2023 | | 2023 |
| O-25 ASSESSMENT OF MODELS FOR PREDICTING RESPONSE TO CORTICOIDS TREATMENT IN ALCOHOL-ASSOCIATED HEPATITIS: A GLOBAL COHORT STUDY F Idalsoaga, LA Díaz, G Ayares, J Arnold, W Dunn, Y Li, A Singal, ... Annals of Hepatology 28, 101035, 2023 | | 2023 |
| Adverse childhood experiences as a background for alcoholic liver disease–cohort analysis of risk score in ALD and non-ALD cirrhosis patients in comparison with the control group KK Sulejova, DJ Havaj, S Selcanová Adamcova, N Bystrianska, ... HEPATOLOGY 76, S965-S966, 2022 | | 2022 |
| ASSESSMENT OF MODELS FOR PREDICTING RESPONSE TO CORTICOIDS TREATMENT IN ALCOHOL-ASSOCIATED HEPATITIS: A GLOBAL COHORT STUDY FJ Idalsoaga, LAD Piga, G Ayares, J Arnold, W Dunn, Y Li, AK Singal, ... HEPATOLOGY 76, S1009-S1011, 2022 | | 2022 |
| PREDICTORS OF FECAL MICROBIOTA TRANSPLANTATION FAILURE (FMT) IN SEVERE ALCOHOLIC HEPATITIS (SAH). N Bystrianska, L Skladany, D Zilincanova, J Vnencakova, L Laffers, ... HEPATOLOGY 76, S115-S116, 2022 | | 2022 |
| Fecal microbiota transplantation (FMT) for corticosteroids (CS) non-responders and non-eligible (NoReNE) patients with severe alcoholic hepatitis (SAH) N Bystrianska, J Vnenčáková, D Janceková, L Laffers, Ľ Skladaný JOURNAL OF HEPATOLOGY 75, S407-S408, 2021 | | 2021 |
| Time-to tertiary care predicts mortality in alcohol-associated hepatitis in patients with cirrhosis L Skladaný, D Jancekova, N Bystrianska, J Vnencakova, L Laffers, ... Hepatology, 261A-262A, 2021 | | 2021 |
